Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0EL3A
|
||||
| Former ID |
DNC008333
|
||||
| Drug Name |
N-hydroxy-4-(oleamidomethyl)benzamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C26H42N2O3
|
||||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)NCC1=CC=C(C=C1)C(=O)NO
|
||||
| InChI |
1S/C26H42N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-25(29)27-22-23-18-20-24(21-19-23)26(30)28-31/h9-10,18-21,31H,2-8,11-17,22H2,1H3,(H,27,29)(H,28,30)/b10-9-
|
||||
| InChIKey |
SINCREJZYIHLQD-KTKRTIGZSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Lethal factor | Target Info | Inhibitor | [1] | |
| Pathway Interaction Database | Cellular roles of Anthrax toxin | ||||
| Reactome | Uptake and function of anthrax toxins | ||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2008 Apr 1;18(7):2467-70. Epub 2008 Feb 20.Inhibitors of anthrax lethal factor based upon N-oleoyldopamine. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.